echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Drugs Articles > The effect of tax reduction and fee reduction is remarkable, and pharmaceutical equipment enterprises have accumulated development potential

    The effect of tax reduction and fee reduction is remarkable, and pharmaceutical equipment enterprises have accumulated development potential

    • Last Update: 2020-01-06
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    [trends of pharmaceutical network industry] since 2019, the state has issued a series of positive fiscal policies, among which tax reduction and fee reduction policy highlights, benefiting thousands of enterprises and individuals As a member of the manufacturing industry, many pharmaceutical equipment enterprises say that the effect of tax reduction and fee reduction is significant, which has accumulated the potential for development From April 1, 2019, the VAT rate of manufacturing industry and other industries in China has been reduced from 16% to 13%, and the tax reduction is much stronger than expected According to the data of the Ministry of finance, in the first three quarters of 2019, China's tax reduction and fee reduction totaled 1783.4 billion yuan, of which 182.7 billion yuan was added in the inclusive policy for small and micro enterprises At present, many pharmaceutical equipment enterprises have reported that since the implementation of the tax reduction and fee reduction policy in 2019, the tax reduction effect of the company has been obvious and the sense of gain has been significantly improved, and many small and medium-sized enterprises have obtained the "accelerator" of climbing over the hurdle with the help of the "red packet rain" of tax reduction and fee reduction "The tax cut policy has greatly reduced the capital occupation, let us have more funds for R & D and innovation, and let employees also enjoy the real tax cut dividend." Pharmaceutical machinery enterprises with small-scale operation said that in 2020, the company will continue to increase R & D and talent introduction, and continue to create more green, intelligent environmental protection and efficient products There are pharmaceutical machinery enterprises said that the company has enjoyed the reduction rate of value-added tax, R & D expenses plus deduction and other preferential policies "If we sell 1.5 billion yuan domestically in 2019, VAT can save nearly 15 million yuan; the proportion of R & D plus deduction is adjusted from 50% to 75%, R & D investment is 200 million yuan, and corporate income tax can save nearly 4 million yuan." This saved capital can help enterprises to save energy for development and create more scientific and technological achievements Leading enterprises continue to strengthen talent introduction and R & D according to the data of the Ministry of finance, 45% of manufacturing taxpayers will use tax reduction and fee reduction bonus to increase R & D investment in the first three quarters of 2019; in addition, R & D expenses of 100000 key tax source enterprises monitored by the tax department increased by 19.3% year on year In the "red envelope rain" of tax reduction and fee reduction policies, some large domestic enterprises in the field of pharmaceutical equipment are also making full use of their energy and continue to invest in the introduction and research and development of enterprise talents Tang Yue, chairman of truking, said that the reform dividend is not only reflected in tax reduction and fee reduction, but also in the further harmonious relationship between tax enterprises, which provides a good tax business environment for the development of enterprises According to one of its accounts, according to the business scale in 2018, truking technology will reduce taxes by more than 20 million yuan in 2019 "If this money is used to introduce high-tech talents, its benefits will be multiplied." It is reported that under the background of intelligent pharmaceutical industry becoming the general trend, truking technology is making efforts to "produce pharmaceutical robots with industrial robots" At present, truking technology intelligent factory is in the final acceptance It is understood that after the project is completed and put into production, truking will have a variety of pharmaceutical robots, such as detection robots, filling robots, aseptic transfer robots, etc., flexible manufacturing lines, intelligent factories for personalized pharmaceutical equipment, and a public service platform for robots and intelligent equipment suitable for the upgrading and transformation of China's pharmaceutical industry This will make the pharmaceutical process more safe and controllable It will also promote the transformation and upgrading of the whole industry and improve the intelligent and international level of Chinese pharmaceutical equipment With the support of tax reduction and fee reduction policy, truking will continue to vigorously promote the strategy of "one vertical, one horizontal and one platform" "One vertical" refers to the whole industrial chain of sterile pharmaceutical production equipment, "one horizontal" refers to the whole product chain covering major pharmaceutical dosage form equipment, "one platform" refers to intelligent + Mobile Internet platform Coincidentally, on April 1, 2019, when the new VAT rate was implemented, DFL successfully issued the first VAT invoice with a 13% tax rate It is reported that since the end of the new GMP certification peak, DFL has been faced with the challenges of labor costs rising too fast and various expenses It can be seen that the implementation of tax reduction and fee reduction policy is conducive to further reducing the pressure of the company and making it better invested in R & D At present, under the influence of policies such as new drug approval reform, pilot of listing license holder system, generic drug consistency evaluation, and "4 + 7 volume procurement", the pharmaceutical industry is in the transition period of technology update and iteration, while DFL can provide global pharmaceutical enterprises with pharmaceutical technology, core equipment, and overall solution services of system engineering It is reported that different from the traditional design concept, DFL intelligent engineering department is able to build a personalized and automated intelligent pharmaceutical factory for customers from the perspective of customized system, integrate the concept of information and automation in the design stage, and provide a precise plan that can be landed, so as to reduce cost input, reduce energy consumption, and protect the safety of production and operation personnel Conclusion: in general, capital is the key to the development of pharmaceutical equipment enterprises With the implementation of favorable policies such as tax reduction and fee reduction, it is beneficial for Chinese pharmaceutical equipment enterprises to further solve the problem of weak potential, invest more enthusiasm in the R & D and production process, and help the whole industry steadily improve quality and efficiency.
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.